Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 30, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Extracellular Matrix-Related Prognostic Signature for Head and Neck Squamous Cell Carcinoma via Multi-Algorithm

Wenwen Chen1,2, Yehai Liu1

  • 1Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Biomarker Insights
|June 29, 2026
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of transcutaneous electrical acupoint stimulation combined with ear copper needle scraping on the clinical efficacy and quality of life of patients with sudden sensorineural hearing loss accompanied by tinnitus: A randomized controlled trial.

American journal of otolaryngology·2026
Same author

SLC16A1 Activates the STAT3/SLC7A11 Pathway to Mediate Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma.

Oncology research·2026
Same author

IGF2BP3 Promotes Head and Neck Squamous Cell Carcinoma Progression via the M6A-LDHA-Lactate-H4K8la Axis and E2F2 Activation.

Technology in cancer research & treatment·2026
Same author

TRAPPC4 Promotes GPX4 Stability to Drive Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma.

Cancer research·2026
Same author

Transcutaneous Electrical Nerve Stimulation for Subjective Tinnitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026
Same author

Thyroid Foramen in Living Participants and Its Mesoscopic Anatomy.

Journal of voice : official journal of the Voice Foundation·2025

A new extracellular matrix-related signature (ECMS) shows prognostic value in head and neck squamous cell carcinoma (HNSCC). This signature may help predict patient outcomes and guide therapy in HNSCC.

Area of Science:

  • Oncology
  • Bioinformatics
  • Molecular Biology

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is associated with poor prognosis.
  • The extracellular matrix (ECM) significantly influences tumor progression and is a potential therapeutic and prognostic target in HNSCC.

Purpose of the Study:

  • To develop and validate an ECM-related prognostic signature (ECMS) for HNSCC.
  • To investigate the association between the ECMS, immune features, and therapeutic responses in HNSCC.

Main Methods:

  • Utilized a retrospective, multi-cohort study integrating transcriptomic analysis and machine learning.
  • Developed and validated an ECMS using 10 machine learning algorithms and 101 combinations.
  • Integrated ECMS with clinical variables for prognosis prediction and analyzed immune infiltration and treatment responses.
Keywords:
extracellular matrixhead and neck squamous cell carcinomamachine learningprognosistherapy sensitivity

Related Experiment Videos

Last Updated: Jun 30, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Main Results:

  • Identified 23 ECM genes significantly associated with HNSCC prognosis.
  • The developed ECMS demonstrated consistent predictive performance across validation cohorts.
  • Observed significant differences in immune cell infiltration and immune checkpoint gene expression between high- and low-risk groups, with WNT7A promoting HNSCC progression.

Conclusions:

  • An ECMS with prognostic value was developed for HNSCC.
  • The ECMS may enhance existing clinical variables for predicting HNSCC outcomes.
  • The findings suggest ECM-related genes as potential therapeutic targets in HNSCC.